Results
1 -
8 of
8Oleuropein potently inhibits mammalian target of rapamycin: possible involvement of tandem anomeric hyperconjugation?Michael reaction, Medicinal Chemistry Research Management of Advanced Endometrial Cancer and Inhibitors of the PI3K/AKT/mTOR Pathway, Pelvic Cancer Surgery Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in KrasG12D-LSL mice, Cancer Chemotherapy and Pharmacology Patient-derived xenografts reveal limits to PI3K/mTOR- and MEK-mediated inhibition of bladder cancer, Cancer Chemotherapy and Pharmacology A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer, Targeted Oncology Erratum to: Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer, Investigational New Drugs Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells, International Journal of Hematology TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways, Journal of Experimental & Clinical Cancer Research